Susan Dana Jones serves as Executive at Tourmaline Bio, Inc., where they oversee executive responsibilities. Since joining the company, Susan Dana Jones has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 28, 2025 involved selling 3,152 shares valued at $0.
Susan Dana Jones currently holds 3,152 shares of Tourmaline Bio, Inc. (TRML), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Dana Jones has been a net neutral trader of TRML stock. They have purchased $0 and sold $0 worth of shares.
Susan Dana Jones's most recent insider trade was on Oct 28, 2025, when they sold 3,152 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 19, 2023 | TRML | $0 | Award | 22,934 | $N/A | Discretionary |